The usual disclaimer: I’m not investment advice. I hold $XBI. With thanks to Carl West for editing and feedback. In case you don’t know, the biotech market is down. Like, really down. With the biotech rout in the public markets, I wondered whether there are any trends that can be pulled out of the plungeContinue reading “What ate the public biotech market?”
Against the threat of antibiotic resistant infections, the future is phage.